Cargando…
Selective depletion of radiolabeled HER2-specific antibody for contrast improvement during PET
The prolonged in vivo persistence of antibodies results in high background and poor contrast during their use as molecular imaging agents for positron emission tomography (PET). We have recently described a class of engineered Fc fusion proteins that selectively deplete antigen-specific antibodies w...
Autores principales: | Khare, Priyanka, Sun, Wei, Ramakrishnan, Sreevidhya, Swiercz, Rafal, Hao, Guiyang, Lo, Su-Tang, Nham, Kien, Sun, Xiankai, Ober, Raimund J., Ward, E. Sally |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489906/ https://www.ncbi.nlm.nih.gov/pubmed/34592895 http://dx.doi.org/10.1080/19420862.2021.1976705 |
Ejemplares similares
-
Loss of expression of the recycling receptor, FcRn, promotes tumor cell growth by increasing albumin consumption
por: Swiercz, Rafal, et al.
Publicado: (2016) -
Phagocytosis of antibody‐opsonized tumor cells leads to the formation of a discrete vacuolar compartment in macrophages
por: Velmurugan, Ramraj, et al.
Publicado: (2018) -
Engineered clearing agents for the selective depletion of antigen-specific antibodies
por: Devanaboyina, Siva Charan, et al.
Publicado: (2017) -
Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease
por: Sun, Wei, et al.
Publicado: (2021) -
Engineering a HER2-specific antibody-drug conjugate to increase
lysosomal delivery and therapeutic efficacy
por: Kang, Jeffrey C., et al.
Publicado: (2019)